| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $200K | +80.9% | +53.6% |
| R&D Expense | $724K | +496.6% | +550.8% |
| SG&A Expense | $3.5M | +108.2% | +1055.0% |
| Operating Income | -$6.9M | -280.5% | -1482.4% |
| Interest Expense | $100K | +0.3% | +0.0% |
| Pre-tax Income | -$7.0M | -291.8% | -4757.4% |
| Net Income | -$9.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $33K | -0.7% | -76.6% |
| Current Assets | $2.4M | -68.4% | -23.1% |
| Total Assets | $28.8M | +230.8% | +182.8% |
| Current Liabilities | $6.1M | +2438.6% | +1998.6% |
| Total Liabilities | $12.3M | +3950.7% | +3284.9% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.6M | — | — |
| Investing Cash Flow | -$1.8M | — | — |
| Financing Cash Flow | $7.4M | — | — |
| -409.8% |
| -6220.8% |
| EPS (Basic) | -$0.21 | +81.1% | -2000.0% |
| EPS (Diluted) | -$0.21 | +81.1% | -2000.0% |
| $16.5M |
| +96.1% |
| +67.8% |